Pennsylvania has joined 17 other states in a $4.87 million settlement with GS Labs following a multistate investigation into allegations that the company heavily overcharged for COVID-19 tests and consistently failed to deliver timely results.
Attorney General Dave Sunday announced that Pennsylvanians who used GS Labs between 2020 and 2022 may be eligible for financial restitution. According to investigators, the company systematically exploited the peak of the pandemic by advertising artificially inflated "cash prices" of up to $380 per single test—and nearly $1,000 for multi-panel tests—solely to overcharge insurance providers. Meanwhile, cash-paying customers were left paying rates well above market average.
The investigation also revealed that GS Labs regularly charged unannounced "administrative fees" of up to $49 per test, despite telling patients with insurance that they would face zero out-of-pocket costs. Furthermore, hundreds of thousands of people who were guaranteed results within three days often waited a week or longer to receive them.
Under the terms of the agreement, GS Labs will dedicate $3.6 million of the total settlement purely to consumer refunds across the participating states. Affected Pennsylvanians should expect to receive formal communication from GS Labs with detailed instructions on how to file claims via an online portal.
GS Labs has officially ceased operations and is no longer providing medical testing services. However, under the legally binding settlement, if the company ever attempts to resume operations in the future, it will be strictly mandated to overhaul its billing practices, cap its testing fees, and offer automatic refunds if guaranteed processing times are mi
